Table 5 Predictive values of baseline data for the fulfillment of the remission criteria at 12 months
OR (95%CI) | P value | |
|---|---|---|
Univariate analyses | ||
Absence of gout flares in the previous 12 months | 2.48 (0.82–5.88) | 0.95 |
Age | 1.01 (0.97–1.05) | 0.52 |
Body mass index | 1.10 (0.91–1.35) | 0.33 |
C reactive protein within normal range | 3.0 (0.80–11.19) | 0.10 |
Current SU level | 0.61 (0.33–1.15) | 0.13 |
Disease duration | 0.98 (0.90–1.07) | 0.63 |
Familiar history of gout | 0.95 (0.27–3.32) | 0.94 |
Gender | 0.96 (0.75–1.57) | 0.74 |
Highest ever SU level <535 μmol/l | 2.60 (0.69–9.75) | 0.15 |
Number of comorbidities | 1.12 (0.83–1.49) | 0.46 |
Ongoing flare prophylaxis | 0.23 (0.07–0.75) | 0.02 |
Smoking status (current or previous smoker) | 1.33 (0.24–7.56) | 0.60 |
Absence of MSU crystal deposits—total score=0 | 10.83 (1.14–102.59) | 0.04 |
Absence of aggregates—aggregate score=0 | 5.53 (1.34–22.76) | <0.01 |
Absence of DC sign—DC sign=0 | 7.33 (1.71–31.44) | <0.01 |
Absence of tophi—Tophus score=0 | 3.88 (1.08–13.92) | 0.02 |
Multivariate analyses | ||
Absence of MSU crystal deposits—total score=0 | 10.13 (1.02–100.28) | 0.04 |
Absence of aggregates—aggregate score=0 | 4.80 (1.22–27.92) | 0.03 |
Absence of DC sign—DC sign=0 | 6.61 (1.83–29.67) | 0.01 |
Absence of tophi—Tophus score=0 | 3.80 (1.05–13.75) | 0.04 |